Implantable Medical System Lead Electrode Segmentation for Therapy Continuity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable medical devices face challenges in sustaining therapy delivery due to lead-related conditions such as insulation breaches, conductor fractures, and intermittent contacts, which can lead to short or open circuits, impairing cardiac activity sensing and reducing the effectiveness of pacing or defibrillation therapy.
Innovation Solution
The implementation of an implantable medical system with a lead having a first electrode and an alternate electrode, which switches therapy delivery from the first electrode to the alternate electrode in response to a lead-related condition, and an oversense reduction module that reconfigures therapy and sensing functions to maintain effective therapy delivery through unaffected electrode-conductor sets.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If a single electrode is used for therapy delivery, then the device complexity is reduced, but the reliability deteriorates when lead-related conditions occur
Solution Approach 1:
The lead electrode is segmented into multiple functional zones (first electrode portion and second electrode portion) with different materials or properties, allowing independent operation of each segment. When one segment fails due to lead-related conditions, the other segment can continue to deliver therapy, thus maintaining reliability without requiring a completely redundant lead system.
Solution Approach 2:
Different portions of the electrode are assigned different local qualities (different materials, conductivities, or sensitivities) optimized for specific functions. The first electrode portion may be optimized for pacing while the second is optimized for sensing, or vice versa. This local differentiation allows the system to switch between portions based on operational needs and failure conditions.
2Measurement precision
If lead-related conditions are detected, then the sensing accuracy is maintained, but the therapy delivery effectiveness deteriorates
Solution Approach 1:
The system dynamically switches between different electrode portions based on real-time detection of lead-related conditions. When conditions are detected in one portion, the system transitions to using the other portion for both sensing and therapy delivery, maintaining functionality despite degradation in one area.
Solution Approach 2:
The system continuously monitors for lead-related conditions through the electrode portions and uses this feedback to automatically switch between portions. The sensing function detects impedance changes or signal quality degradation, triggering a switch to the alternative electrode portion to maintain both sensing accuracy and therapy effectiveness.
3Reliability
If multiple electrode portions are provided, then the reliability is improved, but the device complexity increases
Solution Approach 1:
Multiple electrode portions are merged into a single integrated lead structure rather than being separate leads. The first and second electrode portions are combined in one lead, sharing the same insulation and conductor infrastructure, which reduces overall system complexity compared to having duplicate leads while still providing redundancy.
Solution Approach 2:
The lead structure is designed to perform multiple functions through its different portions - both pacing and sensing, with the ability to switch between portions based on operational conditions. This multi-functionality reduces the need for separate dedicated leads for each function, simplifying the overall device architecture.
Data Source
AI summary
The disclosure describes implantable medical systems that respond to occurrence of a lead-related condition by utilizing an elongated coil electrode in defining an alternative pacing therapy vector to maintain optimal drain of an IMD power supply. An exemplary system includes a medical electrical lead having an elongated electrode and an improved sensing and therapy delivery circuitry to provide the alternative pacing therapy vector responsive to the lead-related conditions. The system includes circuitry for recognition of the lead type in order to respond to the occurrence of the lead-related condition.